Brainomix is an award-winning medical diagnostics software company. It was founded in 2010 as a spin-out from the University of Oxford and is dedicated to improving outcomes for patients with neurological and cerebrovascular disorders.
Brainomix is currently focusing on acute stroke. By developing and equipping physicians with world-class, artificial intelligence-based medical imaging software, Brainomix aims to help them in making life-saving treatment decisions by supporting the selection of the right treatment for the right stroke patient.
The company’s products are marketed under the e-Stroke Suite which acts as a standardized and fast decision support tool that helps physicians choose an appropriate treatment based on the quantitative analysis of plain CT, CTA and CT/MR perfusion scans.
For more information, please visit www.brainomix.com